N
NVS
Novartis AG
$146.88
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Novartis AG in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$5.47
Yield
3.72%
EPS
$6.62
P/E
20.2
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $2.32
Oct 27
Posts
No posts about NVS yet.
About Novartis AG
Novartis is a Swiss pharmaceutical company that researches, develops, and sells prescription medicines for conditions like heart disease, cancer, and rare genetic disorders. It makes money by selling branded drugs while they are still protected by patents, which lets it charge premium prices; when those patents expire, cheaper generic copies flood in and cut into sales.